US to fund Georgia scientists to research, clone deadly viruses for 'outbreak response'

[Guest guest]

USDA website 'help wanted' notice...

>>This training includes: vaccine discovery, inclusive of cell

culture, virus titration, virus cloning, viral analysis, sequencing,

tissue collection and necropsy.<<

===========

Research Project: Foreign Animal Disease Vaccines and Diagnostics

Project Number: 1940-32000-050-04

Project Type: Reimbursable

Start Date: Jun 01, 2008

End Date: Sep 30, 2010

Objective:

African Swine Fever Virus (ASFV) has been identified by USDA and DHS

as an emerging agricultural pathogen due to the 2007, outbreaks in

Eurasia and is now a high priority for biological countermeasure

research. The objectives of this collaborative research agreement

are: 1. Identify and recruit a qualified scientist from the Republic

of Georgia to come to ARS, PIADC for the purpose of acquiring

knowledge of ASF, and development of molecular biology skill sets 2.

Development of said skill sets that will be applied to ASF research

and development through ongoing ARS Classical Swine Fever vaccine

discovery. ASFV, a look-a-like virus to CSFV, was previously studied

at ARS, PIADC 3. Initiate planning activities associated with ASF

basic research and vaccine discovery.

Approach:

1. A qualified Republic of Georgia scientist capable of carrying out

the training exercise tasks under minimal supervision and capable of

developing skill sets necessary for the successful ASF knowledge

transfer in the future to other Republic of Georgia scientists. This

scientist will be supported through USDA-DOE interagency agreement

administered through ORISE. 2. The identified Republic of Georgia

scientist will be trained by ARS, PIADC in foreign animal disease

molecular biology skills through on-going ARS Classical Swine Fever

research. This training includes: vaccine discovery, inclusive of

cell culture, virus titration, virus cloning, viral analysis,

sequencing, tissue collection and necropsy. DHS, PIADC will

coordinate ASFV related activities between ARS, PIADC and the

Republic of Georgia, including access to viral samples and genomic

sequencing support. 3. The identified Republic of Georgia scientist,

with assistance from ARS, PIADC and DHS, PIADC collaborators, will

prepare and submit an ASF basic research and vaccine discovery

proposal targeting the Eurasian outbreak response.

Last Modified: 08/15/2008

=====

In accordance with Title 17 U.S.C. Section 107, this material is

distributed without profit to those who have expressed a prior

interest in receiving the included information for research and

educational purposes.

[Guest guest]

USDA website 'help wanted' notice...

>>This training includes: vaccine discovery, inclusive of cell

culture, virus titration, virus cloning, viral analysis, sequencing,

tissue collection and necropsy.<<

===========

Research Project: Foreign Animal Disease Vaccines and Diagnostics

Project Number: 1940-32000-050-04

Project Type: Reimbursable

Start Date: Jun 01, 2008

End Date: Sep 30, 2010

Objective:

African Swine Fever Virus (ASFV) has been identified by USDA and DHS

as an emerging agricultural pathogen due to the 2007, outbreaks in

Eurasia and is now a high priority for biological countermeasure

research. The objectives of this collaborative research agreement

are: 1. Identify and recruit a qualified scientist from the Republic

of Georgia to come to ARS, PIADC for the purpose of acquiring

knowledge of ASF, and development of molecular biology skill sets 2.

Development of said skill sets that will be applied to ASF research

and development through ongoing ARS Classical Swine Fever vaccine

discovery. ASFV, a look-a-like virus to CSFV, was previously studied

at ARS, PIADC 3. Initiate planning activities associated with ASF

basic research and vaccine discovery.

Approach:

1. A qualified Republic of Georgia scientist capable of carrying out

the training exercise tasks under minimal supervision and capable of

developing skill sets necessary for the successful ASF knowledge

transfer in the future to other Republic of Georgia scientists. This

scientist will be supported through USDA-DOE interagency agreement

administered through ORISE. 2. The identified Republic of Georgia

scientist will be trained by ARS, PIADC in foreign animal disease

molecular biology skills through on-going ARS Classical Swine Fever

research. This training includes: vaccine discovery, inclusive of

cell culture, virus titration, virus cloning, viral analysis,

sequencing, tissue collection and necropsy. DHS, PIADC will

coordinate ASFV related activities between ARS, PIADC and the

Republic of Georgia, including access to viral samples and genomic

sequencing support. 3. The identified Republic of Georgia scientist,

with assistance from ARS, PIADC and DHS, PIADC collaborators, will

prepare and submit an ASF basic research and vaccine discovery

proposal targeting the Eurasian outbreak response.

Last Modified: 08/15/2008

=====

In accordance with Title 17 U.S.C. Section 107, this material is

distributed without profit to those who have expressed a prior

interest in receiving the included information for research and

educational purposes.